BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8489288)

  • 21. Successful downstaging by S-1-based chemotherapy followed by surgical resections for gastric carcinoma with extensive distant lymph node metastasis - report of two cases and a review of cases with surgical resection after downstaging by S-1-based chemotherapy.
    Yoshida I; Sakurai Y; Komori Y; Tonomura S; Masui T; Shoji M; Nakamura Y; Imazu H; Uyama I; Ochiai M
    Hepatogastroenterology; 2005; 52(63):978-84. PubMed ID: 15966245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute study.
    Nio Y; Koike M; Omori H; Hashimoto K; Itakura M; Yano S; Higami T; Maruyama R
    Anticancer Res; 2004; 24(3b):1879-87. PubMed ID: 15274369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring of anticancer drug effects in vivo by serial DNA flow cytometry of oral carcinomas treated by intra-arterial 5-fluorouracil/cisplatin induction chemotherapy.
    Hemmer J; Kreidler J; Kraft K; Schön E
    Anticancer Res; 1994; 14(5B):2077-83. PubMed ID: 7840503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
    Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of cellular DNA content by flow cytometry in epidermoid carcinoma of the esophagus].
    Charneau J; Chassevent A; Delaby J; Ben Bouali AK; Larra F; Boyer J
    Gastroenterol Clin Biol; 1992; 16(2):155-61. PubMed ID: 1568543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined S-1 and cisplatin preoperative chemotherapy for patients with advanced gastric cancer: report of five cases.
    Nakane Y; Inoue K; Michiura T; Nakai K; Sato M; Baden T; Okumura S; Yamamichi K
    Hepatogastroenterology; 2004; 51(55):289-93. PubMed ID: 15011888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interim report of JFMC study no. 23--phase III randomized clinical trial on the effectiveness of low-dose cisplatin plus 5-FU as a postoperative adjuvant chemotherapy for advanced gastric cancer].
    Saji S; Toge T; Kurosu Y; Hirata K; Gochi A; Tominaga S; Inokuchi K
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2499-507. PubMed ID: 12506472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of advanced gastric carcinoma successfully treated with TS-1/CDDP as a neoadjuvant chemotherapy].
    Kawami H; Shigematsu H; Fujimoto Y
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):1003-7. PubMed ID: 12894719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemotherapy of Borrmann's type IV diffuse carcinoma of the stomach].
    Suga S; Kimura K; Yokoyama Y
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2478-84. PubMed ID: 6418076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
    Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
    Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Case of stage IVb gastric cancer in which favorable anti-tumor effect and good QOL were observed due to UFTP therapy after low-dose CDDP-tegafur therapy].
    Takai S; Taki S; Fujino R; Oshita M; Otsuka T; Hirose Y; Sumitomo M; Hayashi N; Nagano T; Matsumura M
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):2077-80. PubMed ID: 10584575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [UFT-therapy and UFTM therapy--comparison of survivals in the patients with Borrmann type 4 gastric cancer treated either with UFTM-chemotherapy or operation].
    Suga S; Kimura K; Yokoyama Y
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):769-74. PubMed ID: 6424582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis.
    Esteban F; de Vega DS; Garcia R; Rodriguez R; Manzanares J; Almeida A; Tamames S
    Hepatogastroenterology; 1999; 46(27):2039-43. PubMed ID: 10430394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on neoadjuvant chemotherapy of Borrmann 4 type carcinoma of stomach and its clinical significance].
    Mai M; Ogino T; Ueda H; Ooi A; Takahashi Y; Sawaguchi K; Suga T; Ohta T; Asai T; Itoh T
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):586-97. PubMed ID: 2351851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response].
    Káposztás Z; Cseke L; Kalmár K; Horváth OP
    Magy Seb; 2002 Oct; 55(5):321-4. PubMed ID: 12474518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interim report on JFMTC Study no. 21 on the effectiveness of UFT as an adjuvant therapy for semi-advanced cancer of the stomach].
    Yoshino K; Fujita M; Hirata K; Kunii Y; Kitamura M; Nagawa H; Kubota T; Wakasugi J; Kasai Y; Takahashi Y; Furukawa H; Takao T; Kaibara N; Takashima S; Kakegawa T; Tomita M; Nose Y
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):263-70. PubMed ID: 10700898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [UFT/CDDP preoperative chemotherapy for progressive gastric cancer--histological antitumor effects and thymidylate synthase inhibition rate].
    Tanaka S; Umeno T; Mitsuishi K; Tomita A; Ootsuka K; Mori H; Nakamura H; Ikeda S
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1947-51. PubMed ID: 7487125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A patient with advanced gastric cancer surviving for more than 5 years after neoadjuvant chemotherapy and curative resection].
    Hirota M; Kimura J; Eguchi T; Kato K; Kobayashi H; Kanazumi N; Suzuki Y; Ishii M
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):125-9. PubMed ID: 11816468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of advanced gastric cancer attaining histological CR of paraaortic lymph node after TS-1/CDDP neoadjuvant chemotherapy].
    Koizumi Y; Hara A; Tomita M; Sakamoto K; Obata H; Shiomi T; Nakajo S; Hashimoto K
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1351-6. PubMed ID: 14518420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients.
    Yonemura Y; Kinoshita K; Fujimura T; Fushida S; Sawa T; Matsuki N; Tanaka S; Kamata T; Takashima T; Miyazaki I
    Hepatogastroenterology; 1996; 43(11):1260-72. PubMed ID: 8908561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.